Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
Condition: Coronary Heart Disease (CHD)Interventions: Other: Treatment of CHD risk factors; Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.; Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.; Procedure: PCA; Procedure: CABG; Device: Cardiospec; Drug: Aspirin, Isosorbide mononitrate, Atenolol, EnalaprilSponsors: City Hospital No 40, Saint Petersburg, Russia; City Hospital No 40, Saint Petersburg, RussiaNot yet recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2012 Category: Research Source Type: clinical trials
Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
Condition: Coronary Heart Disease (CHD)Interventions: Other: Treatment of CHD risk factors; Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.; Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.; Procedure: PCA; Procedure: CABG; Device: Cardiospec; Drug: Aspirin, Isosorbide mononitrate, Atenolol, EnalaprilSponsor: City Hospital No 40, Saint Petersburg, RussiaWithdrawn - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2012 Category: Research Source Type: clinical trials
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
Conditions: Postural Orthostatic Tachycardia Syndrome; Orthostatic Intolerance Interventions: Drug: Droxidopa; Drug: Atenolol; Drug: Placebos Sponsors: Beth Israel Deaconess Medical Center; National Heart, Lung, and Blood Institute (NHLBI) Terminated - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2012 Category: Research Source Type: clinical trials
